Numano Type V Takayasu Arteritis Patients Are More Prone to Have Coronary Artery Involvement

Overview

Journal Clin Rheumatol

Publisher Springer

Specialty Rheumatology

Date 2020 May 20

PMID 32424657

Citations 3

Authors

Taotao Li

Juan Du

Na Gao

Xi Guo

Lili Pan

Affiliations

Soon will be listed here.

Abstract

Objectives: Takayasu arteritis (TA) is a rare granulomatous vasculitis. Numano type V was the most frequently involved arteritis in China. In our study, we aimed to investigate the characteristics of the type V TA in Chinese people.

Methods: We retrospectively reviewed 143 medical charts of TA patients who were admitted to Beijing Anzhen Hospital from 2012 to 2019. All statistical studies were carried out with the SPSS program V.24.0.

Results: The duration of disease at first admission of type V TA patients was longer than non-type V group (110.6 (21.0, 168.0) vs. 69.1 (12.0, 120.0) months, P = 0.034). The incidences of hypertension and coronary artery involvement were more common in type V TA patients compared with non-type V patients (59.5% vs. 30.4%, P < 0.001; 33.8% vs. 17.4%, P = 0.025; respectively). The numbers of platelet (PLT) and the plateletcrit (PCT) in type V TA patients were significantly smaller than those in non-type V group (244.9 (190.5, 293.8) vs. 281.6 (214.5, 332.0) × 10/L, P = 0.005; 0.25 (0.20, 0.28) vs. 0.28 (0.22, 0.32) %, P = 0.003; respectively). Lesions located in the left anterior descending coronary (LAD) and the left circumflex coronary (LCX) presented more frequently in type V TA patients than in non-type V patients (LAD 76.0 vs. 41.7%, P = 0.041; LCX 56.0 vs. 8.3%, P = 0.006; respectively).

Conclusions: Type V TA patients had longer disease duration and higher incidence of hypertension and were more prone to have coronary artery involvement compared with non-type V patients. Key Points • This study is the first to assess characteristics of the type V TA in Chinese people. • Type V TA patients had longer disease duration and higher incidence of hypertension and were more prone to have coronary artery involvement compared with non-type V patients. • The numbers of platelet (PLT) and the plateletcrit (PCT) in type V TA patients were significantly smaller than those in non-type V group.

Citing Articles

The long-term success of cardiovascular surgery in Takayasu arteritis: 48 years of experience in Mexico, beyond forefront techniques.

Soto M, Gomez-Savinon V, Vasquez-Jimenez C, Barragan-Garcia R, Hernandez-Mejia I, Koretzky S J Thorac Dis. 2025; 16(12):8482-8492.

PMID: 39831257 PMC: 11740032. DOI: 10.21037/jtd-24-709.

CD8 cell-derived granzyme B may be a predictor for coronary artery involvement and MACE in Takayasu arteritis patients.

Li T, Gao N, Du J, Zhao L, Yang S, Zhang Y Clin Exp Immunol. 2024; 219(1).

PMID: 39432677 PMC: 11773806. DOI: 10.1093/cei/uxae095.

Coronary artery lesions in Takayasu arteritis.

Dzhus M, Mostbauer H Reumatologia. 2024; 61(6):460-472.

PMID: 38322104 PMC: 10839913. DOI: 10.5114/reum/176483.

Mismatch of systematic and local inflammatory activity in Takayasu arteritis with coronary involvement: a case report.

Nan N, Pan L, Dong R, Song X Eur Heart J Case Rep. 2023; 7(8):ytad346.

PMID: 37554963 PMC: 10406451. DOI: 10.1093/ehjcr/ytad346.

Monocyte-to-high-density lipoprotein ratio as a predictor for patients with Takayasu arteritis and coronary involvement: a double-center, observational study.

Ci W, Wan J, Han J, Zou K, Ge C, Pan L Front Immunol. 2023; 14:1120245.

PMID: 37426640 PMC: 10324657. DOI: 10.3389/fimmu.2023.1120245.

References

Keser G, Aksu K, Direskeneli H . Takayasu arteritis: an update. Turk J Med Sci. 2018; 48(4):681-697. DOI: 10.3906/sag-1804-136. View

Grayson P, Maksimowicz-McKinnon K, Clark T, Tomasson G, Cuthbertson D, Carette S . Distribution of arterial lesions in Takayasu's arteritis and giant cell arteritis. Ann Rheum Dis. 2012; 71(8):1329-34. PMC: 3729734. DOI: 10.1136/annrheumdis-2011-200795. View

Mason J . Takayasu arteritis--advances in diagnosis and management. Nat Rev Rheumatol. 2010; 6(7):406-15. DOI: 10.1038/nrrheum.2010.82. View

Yang S, Dong K, Zheng S . Abdominal pain as the presenting symptom of Takayasu arteritis in an adolescent male: A case report. Medicine (Baltimore). 2018; 97(26):e11326. PMC: 6039581. DOI: 10.1097/MD.0000000000011326. View

Baymakova M, Demirev A, Kostadinova I, Andonova R, Popov G, Plochev K . Giant-cell arteritis without cranial manifestations presenting as fever of unknown origin: a diagnostic value of 18F-FDG PET/CT. Clin Ter. 2018; 169(6):e274-e276. DOI: 10.7417/CT.2018.2092. View

Dourmishev A, Serafimova D, Vassileva S, Dourmishev L, Schwartz R . Segmental ulcerative vasculitis: a cutaneous manifestation of Takayasu's arteritis. Int Wound J. 2006; 2(4):340-5. PMC: 7951509. DOI: 10.1111/j.1742-4801.2005.00103.x. View

Gonzalez-Gay M, Prieto-Pena D, Martinez-Rodriguez I, Calderon-Goercke M, Banzo I, Blanco R . Early large vessel systemic vasculitis in adults. Best Pract Res Clin Rheumatol. 2019; 33(4):101424. DOI: 10.1016/j.berh.2019.06.006. View

Saritas F, Donmez S, Direskeneli H, Pamuk O . The epidemiology of Takayasu arteritis: a hospital-based study from northwestern part of Turkey. Rheumatol Int. 2016; 36(7):911-6. DOI: 10.1007/s00296-016-3445-z. View

Nazareth R, Mason J . Takayasu arteritis: severe consequences of delayed diagnosis. QJM. 2010; 104(9):797-800. DOI: 10.1093/qjmed/hcq193. View

10.

Mirouse A, Biard L, Comarmond C, Lambert M, Mekinian A, Ferfar Y . Overall survival and mortality risk factors in Takayasu's arteritis: A multicenter study of 318 patients. J Autoimmun. 2018; 96:35-39. DOI: 10.1016/j.jaut.2018.08.001. View

11.

Neto N, Shinjo S, Levy-Neto M, Pereira R . Vascular surgery: the main risk factor for mortality in 146 Takayasu arteritis patients. Rheumatol Int. 2017; 37(7):1065-1073. DOI: 10.1007/s00296-017-3656-y. View

12.

Hata A, Noda M, Moriwaki R, Numano F . Angiographic findings of Takayasu arteritis: new classification. Int J Cardiol. 1997; 54 Suppl:S155-63. DOI: 10.1016/s0167-5273(96)02813-6. View

13.

Li J, Sun F, Chen Z, Yang Y, Zhao J, Li M . The clinical characteristics of Chinese Takayasu's arteritis patients: a retrospective study of 411 patients over 24 years. Arthritis Res Ther. 2017; 19(1):107. PMC: 5445478. DOI: 10.1186/s13075-017-1307-z. View

14.

Toshihiko N . Current status of large and small vessel vasculitis in Japan. Int J Cardiol. 1997; 54 Suppl:S91-8. DOI: 10.1016/s0167-5273(96)88777-8. View

15.

Suwanwela N, Piyachon C . Takayasu arteritis in Thailand: clinical and imaging features. Int J Cardiol. 1997; 54 Suppl:S117-34. DOI: 10.1016/s0167-5273(96)88781-x. View

16.

Sanchez-Alvarez C, Mertz L, Thomas C, Cochuyt J, Abril A . Demographic, Clinical, and Radiologic Characteristics of a Cohort of Patients with Takayasu Arteritis. Am J Med. 2019; 132(5):647-651. DOI: 10.1016/j.amjmed.2018.12.017. View

17.

Li J, Li H, Sun F, Chen Z, Yang Y, Zhao J . Clinical Characteristics of Heart Involvement in Chinese Patients with Takayasu Arteritis. J Rheumatol. 2017; 44(12):1867-1874. DOI: 10.3899/jrheum.161514. View

18.

He Y, Lv N, Dang A, Cheng N . Pulmonary Artery Involvement in Patients with Takayasu Arteritis. J Rheumatol. 2019; 47(2):264-272. DOI: 10.3899/jrheum.190045. View

19.

Kerr G, Hallahan C, Giordano J, Leavitt R, Fauci A, Rottem M . Takayasu arteritis. Ann Intern Med. 1994; 120(11):919-29. DOI: 10.7326/0003-4819-120-11-199406010-00004. View

20.

Misra R, Danda D, Rajappa S, Ghosh A, Gupta R, Mahendranath K . Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010). Rheumatology (Oxford). 2013; 52(10):1795-801. DOI: 10.1093/rheumatology/ket128. View